AmerisourceBergen Corp.
ABCUSOpenBack To Top
$
2.30
2.65%
$
89.12
| Previous Close |
|---|
| $86.82 |
Volume:
4.1M
65 Day Avg. - 2M
84.19
Day Low/High
89.67
71.90
52 Week Low/High
106.27
Key Data
- Open $86.82
- Day Range 84.19 - 89.67
- 52 Week Range 71.90 - 106.27
- Market Cap $19.07B
- Shares Outstanding 219.67M
- Public Float 162.2M
- Beta 0.79
- Rev. per Employee $7.77M
- P/E Ratio 19.14
- EPS $4.64
- Yield 1.71%
- Dividend $0.38
- Ex-Dividend Date Feb 16, 2018
- Short Interest 5.34M 03/29/18
- % of Float Shorted 3.29%
- Average Volume 2.02M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Recent News
- MarketWatch
- Other Dow Jones
AmerisourceBergen's stock climbs 1.5%; was down 2.5% before CNBC report of Amazon shelving drug plan
AmerisourceBergen's stock climbs 1.5%; was down 2.5% before CNBC report of Amazon shelving drug plan
AmerisourceBergen, Walgreens shares slide after report that talks have ended without a deal
AmerisourceBergen Corp. shares dropped 6% and Walgreens Boots Alliance shares dropped 2.2% in midday trade Tuesday after a CNBC report said that the two companies' talks ended without a deal. The Wall Street Journal previously reported that Walgreens was in talks to buy AmerisourceBergen. AmerisourceBergen shares have surged 17% over the last three months, while Walgreens shares have declined 1%, compared with a 6.2% rise in the S&P 500 .
Walgreens shares drop 2.2%
Walgreens shares drop 2.2%
AmerisourceBergen shares drop 6.8%
AmerisourceBergen shares drop 6.8%
AmerisourceBergen shares drop 6.8%
AmerisourceBergen shares drop 6.8%
AmerisourceBergen, Walgreens share slide after report that talks have ended without a deal
AmerisourceBergen, Walgreens share slide after report that talks have ended without a deal
Breaking
Dow opens 160 points lower, as stock market threatens to halt 2-day climb
U.S. stock benchmarks point to a modestly lower open on Tuesday. The Dow Jones Industrial Average was 170 points, or 0.7%, lower at 24,448, while the S&P 500 index slipped 15 points, or 0.5%, to 2,642. The Nasdaq Composite Index gave up 31 points, or 0.4%, at 6,952. The main benchmarks are threatening to halt two consecutive days of advances as stocks struggle to recover from its worst week in about two years. Investors have also been weighing a Federal budget that U.S. President Donald Trump has proposed as well as an infrastructure proposal. Looking ahead, Wall Street investors are awaiting key readings of inflation on Wednesday and Thursday. In corporate news, shares of AmerisourceBergen Corp. rose sharply after reports that Walgreens Boots Alliance Inc. has made an offer to buyout the drug distributor.
Walgreens takeover of Amerisource would boost earnings, but rationale puzzling: Jefferies
A takeover of drug distributor AmerisourceBergen Corp. by Walgreens Boots Alliance Inc. would boost Walgreen's per-share earnings, but would be a headscratcher for investors, Jefferies analysts wrote Tuesday. Walgreens recently approached Amerisource CEO Steven Collis with a view to buying the stake in the company it does not already own, as The Wall Street Journal reported late Monday. Walgreens owns a 26% stake in the company. "While we see strategic value in joining forces with a leading drug distributor such as ABC, we believe WBA has already pursued this opportunity when it formed the WBAD purchasing consortium with ABC and acquired its minority stake in the company," Jefferies analysts wrote in a note. "WBA has been openly discussing their intention of continuing to pursue vertical-integration deal opportunities, but acquiring the rest of ABC, while financially-rational, begs the question on what incremental strategic value the deal would bring, especially in light of recent moves by CVS and AET and even ESRX buying eviCore." A deal would however help Walgreens expand in the U.S. and reduce its reliance on the UK's Boots chain, at a time when the UK market is facing reimbursement and macro pressures, they wrote. Walgreens shares were down 1.7% premarket, while Amerisource was up 13%. S&P 500 futures were down 0.4%.
Health care company shares drop sharply on entry by Amazon, Berkshire Hathaway and JPMorgan
Shares of companies across the health care industry, from health insurers to distributors, pharmacy-benefit managers and drugmakers, dropped in premarket trade on Tuesday after Amazon , Berkshire Hathaway and JPMorgan Chase announced plans for a new company to improve their employees' health care. The news hit pharmacy-benefit managers, pharmacy chains and drug distributors among the hardest, with CVS Health Corp. shares dropping 7.6%, Walgreens Boots Alliance shares dropping 5.7%, Express Scripts Holding Company dropping 4.8% and Cardinal Health Inc. shares dropping 4.3%. Several health insurers' shares also fell significantly, including UnitedHealth Group , which dropped 7.2%, Anthem Inc. , which dropped 7%, as well as Aetna Inc. and Humana Inc. . The moves reflect investor concerns that the Amazon, Berkshire Hathaway and JPMorgan initiative could shake up the status quo, especially given the three companies' large size and influential nature, and the potential interest of other employers in joining them. U.S. health care costs continue to rise year over year despite efforts to curb them, and many experts believe the fault lies with too-high prices. The SPDR S&P Biotech ETF declined 1% in premarket trade, as did the Health Care Select Sector SPDR . Shares of the ETFs have surged 15.5% and 12.3% respectively over the last three months, compared with a 10.9% increase in the S&P 500 and a 13.2% rise in the Dow Jones Industrial Average .
Justice Department Asks to Join Opioid Settlement Talks
The Justice Department is ramping up its efforts to curb the opioid epidemic, requesting to join settlement talks in sprawling litigation against the makers and distributors of prescription painkillers.
- on The Wall Street Journal
Walmart-Humana Talks Put Pressure on Remaining Health-Care Players
The emergence of talks between Walmart Inc. and Humana Inc. creates pressure on the health-care companies that haven’t yet made deals, amid the rapid-fire integration that is reshaping the business of managing health care.
- on The Wall Street Journal
The Morning Risk Report: UK Regulator Seeks More Transparency
The U.K.’s Financial Conduct Authority launched a consultation on Wednesday outlining its approach to supervision and enforcement, and is seeking comments until June 21 as part of an effort to be more transparent.
- on The Wall Street Journal
Health-Care Firms Turn to Drugmaker Execs as Businesses Converge
Health-care companies are tapping executives from drugmakers as they seek out finance and other critical skills found outside their core business to help navigate a recent wave of consolidation.
- on The Wall Street Journal
New York City Boosts Funds to Battle Opioid Epidemic
New York City will add $22 million to its efforts to fight the opioid epidemic this year, Mayor Bill de Blasio said.
- on The Wall Street Journal
Amazon: How It Became Corporate America’s ‘Nightmare’
Today, a columnist wrote, “it’s difficult to imagine the company lacking a seat at any table it wants.”
- on Barron's Online
Buying Goldman, Amex, Selling Altaba, Apple
Ohio’s largest pension fund hacked off two-fifths of its stake in Altaba in the fourth quarter.
- on Barron's Online
Cigna Agrees to Buy Express Scripts for More Than $50 Billion
Cigna plans to buy Express Scripts in a cash-and-stock deal worth $54 billion that the companies say will expand their health-care offerings and help them control costs.
- on The Wall Street Journal
They Said What?
Pros offer opinions on the 10-year Treasury bond-yield level that would start to really hurt stocks.
- on Barron's Online
Albertsons Scoops Up Remainder of Rite Aid in Face of Online Threat
Albertsons plans to buy the portion of Rite Aid that isn’t being sold to Walgreens Boots Alliance as retailers of all stripes scramble to respond to a rapidly changing consumer shopping landscape.
- on The Wall Street Journal
Big Stock Buys: Bluebird, Walgreens, Mallinckrodt
Deerfield Management initiated stakes in Walgreens and Bluebird. It tripled the Mallinckrodt position.
- on Barron's Online
Charting the Market
A graphic look at selected stock activity for the week ended February 16, 2018. Includes Arista Networks, Avon Products, and Lumber Liquidators.
- on Barron's Online
Health-Care Deals: An Offer They Can’t Refuse
The health-care industry is in the throes of a major shake-up. That creates a situation in which companies face a greater risk by standing pat than possibly overpaying for an acquisition.
- on The Wall Street Journal
Today’s Top Supply Chain and Logistics News From WSJ
Amazon is heading to the hospital, pharmaceutical providers are consolidating and private-equity is shrugging at privatization in the White House infrastructure plan.
- on The Wall Street Journal
Amazon Hospital-Supply Push Marks Its Latest Move Into Health Care
Amazon is pushing to turn its nascent medical-supplies business into a major supplier to U.S. hospitals and outpatient clinics that could compete with incumbent distributors of items from gauze to hip implants.
- on The Wall Street Journal
Health-Care Distributor Stocks Fall on News of Consolidation and Competition From Amazon
Shares of health-care distributors fell Tuesday on news the sector could experience more consolidation and heightened competition from retail giant Amazon.com Inc.
- on The Wall Street Journal
Stocks to Watch: AmericsourceBergen, Walgreens, PepsiCo, Under Armour, Blue Apron, Amazon, GM
Among the companies with shares expected to trade actively in Tuesday's session are AmerisourceBergen, Walgreens Boots Alliance, PepsiCo, Under Armour and Blue Apron.
- on The Wall Street Journal
The Morning Risk Report: U.S. Treasury Counterterrorism Office Seeks Budget Boost
The U.S. Treasury wants a 30% boost in funding for its counterterrorism office, reflecting the increased use of financial tools to address national-security threats. An increase would follow years of flat funding.
- on The Wall Street Journal
Walgreens Makes Takeover Approach to AmerisourceBergen
Walgreens Boots Alliance has made a takeover approach to drug distributor AmerisourceBergen, a move that could help boost profitability at the drugstore giant and insulate it against threats in an increasingly competitive health-care landscape.
- on The Wall Street Journal
An Rx for Health Care?
Buffett: The ballooning costs of health care act as a hungry tapeworm on the American economy.
- on Barron's Online
Recent News
- Other News
- Press Releases
CNBC: Amazon kills plan to sell drugs to hospitals
- on Seeking Alpha
Big Dividend Growth Does Not Always Mean Big
- on Seeking Alpha
Valuation Dashboard: Healthcare - Update
- on Seeking Alpha
Justice Department Asks to Join Opioid Settlement Talks
- on The Wall Street Journal
Walmart-Humana Talks Put New Pressure on Remaining Players in Health Care
- on The Wall Street Journal
Health-Care Firms Turn to Drugmaker Executives as Businesses Converge
- on The Wall Street Journal
New York City Boosts Funds to Fight Opioid Epidemic
- on The Wall Street Journal
Trump to release opioid epidemic plan
- on Seeking Alpha
What’s LHC Group’s Business Strategy?
- on MarketRealist.com
Analysts’ Ratings for LHC Group and Its Peers in March
- on MarketRealist.com
Valuation Dashboard: Healthcare - Update
- on Seeking Alpha
Key events next week - healthcare (continued #5)
- on Seeking Alpha
Cigna Agrees to Buy Express Scripts for More Than $50 Billion
- on The Wall Street Journal
Premarket analyst action - healthcare (continued)
- on Seeking Alpha
CVS/Express Scripts deal could stoke buying wider buying - Bloomberg
- on Seeking Alpha
Wall Street Breakfast: QE Hints Awaited From ECB
- on Seeking Alpha
Opioid settlement talks hit roadblocks
- on Seeking Alpha
AmerisourceBergen Announces Date and Time forSecond Quarter Fiscal 2018 Earnings Release
- on BusinessWire - BZX
Retail And Wholesale Global Market Report 2018
- on PR Newswire - PRF
AmerisourceBergen to Participate in Barclays Global Healthcare Conference
- on BusinessWire - BZX
World Courier Bolsters Global Presence with New Offices and Enhanced Capabilities
- on BusinessWire - BZX
AmerisourceBergen Declares Quarterly Dividend
- on BusinessWire - BZX
AmerisourceBergen Corporation to Host Earnings Call
- on ACCESSWIRE
AmerisourceBergen Reports Fiscal 2018 First Quarter Results
- on BusinessWire - BZX
BioLife Solutions Announces SAVSU Alliance with World Courier
- on PR Newswire - PRF
AmerisourceBergen Corp.
AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution and Other segments. The Pharmaceutical Distribution segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded on August 28, 2001 and is headquartered in Chesterbrook, PA. (See Full Profile)
Analyst Ratings
Number of Ratings 20
Full Ratings
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Henry Schein Inc. | $10.64B | |
| Omnicell Inc. | $1.74B | |
| Patterson Cos. Inc. | $2.17B | |
| Cardinal Health Inc. | $19.01B | |
| Owens & Minor Inc. | $974.31M |
Competitor Data Provided By
